{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:06:42Z","timestamp":1790359602311,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,2,16]],"date-time":"2011-02-16T00:00:00Z","timestamp":1297814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s00262-011-0981-y","type":"journal-article","created":{"date-parts":[[2011,2,15]],"date-time":"2011-02-15T11:55:29Z","timestamp":1297770929000},"page":"693-703","source":"Crossref","is-referenced-by-count":22,"title":["TH1 predominance is associated with improved survival in pediatric medulloblastoma patients"],"prefix":"10.1007","volume":"60","author":[{"given":"Verena","family":"Wiegering","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Eyrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"W\u00f6lfl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,16]]},"reference":[{"issue":"3","key":"981_CR1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/neuonc\/1.3.212","volume":"1","author":"JG Gurney","year":"1999","unstructured":"Gurney JG, van Wijngaarden E (1999) Extremely low frequency electromagnetic fields (EMF) and brain cancer in adults and children: review and comment. Neuro Oncol 1(3):212\u2013220","journal-title":"Neuro Oncol"},{"issue":"5","key":"981_CR2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1053\/j.seminoncol.2004.07.009","volume":"31","author":"BR Rood","year":"2004","unstructured":"Rood BR, Macdonald TJ, Packer RJ (2004) Current treatment of medulloblastoma: recent advances and future challenges. Semin Oncol 31(5):666\u2013675","journal-title":"Semin Oncol"},{"issue":"10","key":"981_CR3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1056\/NEJMoa042176","volume":"352","author":"S Rutkowski","year":"2005","unstructured":"Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, Graf N, Emser A, Pietsch T, Wolff JE, Kortmann RD, Kuehl J (2005) Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med 352(10):978\u2013986. doi: 10.1056\/NEJMoa042176","journal-title":"N Engl J Med"},{"key":"981_CR4","unstructured":"Ottensmeier H, Frahsek S, Faldum A, Rutkowski S (2010) Longterm neuropsychological follow up of young children with medulloblastoma and ependymoma treated in the trials HIT-SKK 87\/92 and HIT2000. Neuro Oncol 12 (6):ii13"},{"issue":"8","key":"981_CR5","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1200\/JCO.2001.19.8.2302","volume":"19","author":"SL Palmer","year":"2001","unstructured":"Palmer SL, Goloubeva O, Reddick WE, Glass JO, Gajjar A, Kun L, Merchant TE, Mulhern RK (2001) Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis. J Clin Oncol 19(8):2302\u20132308","journal-title":"J Clin Oncol"},{"issue":"8","key":"981_CR6","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1586\/14737175.6.8.1211","volume":"6","author":"S Rutkowski","year":"2006","unstructured":"Rutkowski S (2006) Current treatment approaches to early childhood medulloblastoma. Expert Rev Neurother 6(8):1211\u20131221. doi: 10.1586\/14737175.6.8.1211","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"981_CR7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1586\/14737175.4.4.681","volume":"4","author":"KE Warren","year":"2004","unstructured":"Warren KE, Packer RJ (2004) Current approaches to CNS tumors in infants and very young children. Expert Rev Neurother 4(4):681\u2013690. doi: 10.1586\/14737175.4.4.681","journal-title":"Expert Rev Neurother"},{"issue":"8","key":"981_CR8","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1470-2045(05)70252-7","volume":"6","author":"J Grill","year":"2005","unstructured":"Grill J, Sainte-Rose C, Jouvet A, Gentet JC, Lejars O, Frappaz D, Doz F, Rialland X, Pichon F, Bertozzi AI, Chastagner P, Couanet D, Habrand JL, Raquin MA, Le Deley MC, Kalifa C (2005) Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. Lancet Oncol 6(8):573\u2013580. doi: 10.1016\/S1470-2045(05)70252-7","journal-title":"Lancet Oncol"},{"issue":"3","key":"981_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000077973","volume":"27","author":"JE Wolff","year":"2004","unstructured":"Wolff JE, Finlay JL (2004) High-dose chemotherapy in childhood brain tumors. Onkologie 27(3):239\u2013245. doi: 10.1159\/000077973","journal-title":"Onkologie"},{"issue":"2","key":"981_CR10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1040-8428(01)00156-1","volume":"41","author":"IJ Dunkel","year":"2002","unstructured":"Dunkel IJ, Finlay JL (2002) High-dose chemotherapy with autologous stem cell rescue for brain tumors. Crit Rev Oncol Hematol 41(2):197\u2013204","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"981_CR11","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1182\/blood.V84.7.2221.2221","volume":"84","author":"CL Mackall","year":"1994","unstructured":"Mackall CL, Fleisher TA, Brown MR, Magrath IT, Shad AT, Horowitz ME, Wexler LH, Adde MA, McClure LL, Gress RE (1994) Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 84(7):2221\u20132228","journal-title":"Blood"},{"issue":"1\u20132","key":"981_CR12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/B:NEON.0000021774.79094.25","volume":"67","author":"A Perez-Martinez","year":"2004","unstructured":"Perez-Martinez A, Quintero V, Vicent MG, Sevilla J, Diaz MA, Madero L (2004) High-dose chemotherapy with autologous stem cell rescue as first line of treatment in young children with medulloblastoma and supratentorial primitive neuroectodermal tumors. J Neurooncol 67(1\u20132):101\u2013106","journal-title":"J Neurooncol"},{"issue":"9","key":"981_CR13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1470-2045(05)70291-6","volume":"6","author":"F Berthold","year":"2005","unstructured":"Berthold F, Boos J, Burdach S, Erttmann R, Henze G, Hermann J, Klingebiel T, Kremens B, Schilling FH, Schrappe M, Simon T, Hero B (2005) Myeloablative megatherapy with autologous stem-cell rescue versus oral maintenance chemotherapy as consolidation treatment in patients with high-risk neuroblastoma: a randomised controlled trial. Lancet Oncol 6(9):649\u2013658. doi: 10.1016\/S1470-2045(05)70291-6","journal-title":"Lancet Oncol"},{"issue":"2","key":"981_CR14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1005721510659","volume":"32","author":"E Leo","year":"1997","unstructured":"Leo E, Schlegel PG, Lindemann A (1997) Chemotherapeutic induction of long-term remission in metastatic medulloblastoma. J Neurooncol 32(2):149\u2013154","journal-title":"J Neurooncol"},{"issue":"10","key":"981_CR15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1470-2045(06)70867-1","volume":"7","author":"A Gajjar","year":"2006","unstructured":"Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF, Dauser R, Sanford RA, Fuller C, Lau C, Boyett JM, Wallace D, Gilbertson RJ (2006) Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 7(10):813\u2013820. doi: 10.1016\/S1470-2045(06)70867-1","journal-title":"Lancet Oncol"},{"key":"981_CR16","doi-asserted-by":"crossref","unstructured":"Fleischhack G, Popping K, Hasan C, Utsch B, Juttner J, Bode U (1998) High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study. Klin Padiatr 210(4):248\u2013255. doi: 10.1055\/s-2008-1043887","DOI":"10.1055\/s-2008-1043887"},{"issue":"3","key":"981_CR17","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1200\/JCO.1999.17.3.832","volume":"17","author":"PM Zeltzer","year":"1999","unstructured":"Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, Allen JC, Stevens KR, Stanley P, Li H, Wisoff JH, Geyer JR, McGuire-Cullen P, Stehbens JA, Shurin SB, Packer RJ (1999) Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children\u2019s Cancer Group 921 randomized phase III study. J Clin Oncol 17(3):832\u2013845","journal-title":"J Clin Oncol"},{"issue":"1","key":"981_CR18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1200\/JCO.1998.16.1.222","volume":"16","author":"IJ Dunkel","year":"1998","unstructured":"Dunkel IJ, Boyett JM, Yates A, Rosenblum M, Garvin JH Jr, Bostrom BC, Goldman S, Sender LS, Gardner SL, Li H, Allen JC, Finlay JL (1998) High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children\u2019s Cancer Group. J Clin Oncol 16(1):222\u2013228","journal-title":"J Clin Oncol"},{"issue":"12","key":"981_CR19","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.ejca.2007.05.028","volume":"43","author":"N Meister","year":"2007","unstructured":"Meister N, Shalaby T, von Bueren AO, Rivera P, Patti R, Oehler C, Pruschy M, Grotzer MA (2007) Interferon-gamma mediated up-regulation of caspase-8 sensitizes medulloblastoma cells to radio- and chemotherapy. Eur J Cancer 43(12):1833\u20131841. doi: 10.1016\/j.ejca.2007.05.028","journal-title":"Eur J Cancer"},{"issue":"40","key":"981_CR20","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1038\/sj.onc.1203816","volume":"19","author":"MA Grotzer","year":"2000","unstructured":"Grotzer MA, Eggert A, Zuzak TJ, Janss AJ, Marwaha S, Wiewrodt BR, Ikegaki N, Brodeur GM, Phillips PC (2000) Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression. Oncogene 19(40):4604\u20134610. doi: 10.1038\/sj.onc.1203816","journal-title":"Oncogene"},{"issue":"1","key":"981_CR21","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0959-8049(01)00355-0","volume":"38","author":"TJ Zuzak","year":"2002","unstructured":"Zuzak TJ, Steinhoff DF, Sutton LN, Phillips PC, Eggert A, Grotzer MA (2002) Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour\/medulloblastoma. Eur J Cancer 38(1):83\u201391","journal-title":"Eur J Cancer"},{"key":"981_CR22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0065-2776(08)60788-9","volume":"73","author":"JC Reed","year":"1999","unstructured":"Reed JC (1999) Caspases and cytokines: roles in inflammation and autoimmunity. Adv Immunol 73:265\u2013299","journal-title":"Adv Immunol"},{"issue":"37","key":"981_CR23","doi-asserted-by":"crossref","first-page":"5125","DOI":"10.1038\/sj.onc.1209518","volume":"25","author":"S Fulda","year":"2006","unstructured":"Fulda S, Debatin KM (2006) 5-Aza-2\u2019-deoxycytidine and IFN-gamma cooperate to sensitize for TRAIL-induced apoptosis by upregulating caspase-8. Oncogene 25(37):5125\u20135133. doi: 10.1038\/sj.onc.1209518","journal-title":"Oncogene"},{"key":"981_CR24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.immunol.15.1.563","volume":"15","author":"EA Bach","year":"1997","unstructured":"Bach EA, Aguet M, Schreiber RD (1997) The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 15:563\u2013591. doi: 10.1146\/annurev.immunol.15.1.563","journal-title":"Annu Rev Immunol"},{"key":"981_CR25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","volume":"15","author":"U Boehm","year":"1997","unstructured":"Boehm U, Klamp T, Groot M, Howard JC (1997) Cellular responses to interferon-gamma. Annu Rev Immunol 15:749\u2013795. doi: 10.1146\/annurev.immunol.15.1.749","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"981_CR26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1359-6101(01)00038-7","volume":"13","author":"H Ikeda","year":"2002","unstructured":"Ikeda H, Old LJ, Schreiber RD (2002) The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev 13(2):95\u2013109","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10","key":"981_CR27","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1200\/JCO.2008.17.9432","volume":"27","author":"S Pfister","year":"2009","unstructured":"Pfister S, Remke M, Benner A, Mendrzyk F, Toedt G, Felsberg J, Wittmann A, Devens F, Gerber NU, Joos S, Kulozik A, Reifenberger G, Rutkowski S, Wiestler OD, Radlwimmer B, Scheurlen W, Lichter P, Korshunov A (2009) Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol 27(10):1627\u20131636. doi: 10.1200\/JCO.2008.17.9432","journal-title":"J Clin Oncol"},{"key":"981_CR28","doi-asserted-by":"crossref","unstructured":"Packer RJ (2005) Medulloblastoma. J Neurosurg 103(4 Suppl):299\u2013300. doi: 10.3171\/ped.2005.103.4.0299 (discussion 300\u2013291)","DOI":"10.3171\/ped.2005.103.4.0299"},{"issue":"9","key":"981_CR29","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1158\/1078-0432.CCR-06-1779","volume":"13","author":"S Rutkowski","year":"2007","unstructured":"Rutkowski S, von Bueren A, von Hoff K, Hartmann W, Shalaby T, Deinlein F, Warmuth-Metz M, Soerensen N, Emser A, Bode U, Mittler U, Urban C, Benesch M, Kortmann RD, Schlegel PG, Kuehl J, Pietsch T, Grotzer M (2007) Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT\u201991. Clin Cancer Res 13(9):2651\u20132657. doi: 10.1158\/1078-0432.CCR-06-1779","journal-title":"Clin Cancer Res"},{"key":"981_CR30","doi-asserted-by":"crossref","unstructured":"Shalaby T, von Bueren AO, Hurlimann ML, Fiaschetti G, Castelletti D, Masayuki T, Nagasawa K, Arcaro A, Jelesarov I, Shin-ya K, Grotzer M (2010) Disabling c-Myc in childhood medulloblastoma and atypical teratoid\/rhabdoid tumor cells by the potent G-quadruplex interactive agent S2T1-6OTD. Mol Cancer Ther 9(1):167\u2013179. doi: 10.1158\/1535-7163.MCT-09-0586","DOI":"10.1158\/1535-7163.MCT-09-0586"},{"issue":"3","key":"981_CR31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2141.2009.07862.x","volume":"147","author":"M Eyrich","year":"2009","unstructured":"Eyrich M, Wiegering V, Lim A, Schrauder A, Winkler B, Schlegel PG (2009) Immune function in children under chemotherapy for standard risk acute lymphoblastic leukaemia - a prospective study of 20 paediatric patients. Br J Haematol 147(3):360\u2013370. doi: 10.1111\/j.1365-2141.2009.07862.x","journal-title":"Br J Haematol"},{"issue":"1","key":"981_CR32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-1759(98)00200-2","volume":"223","author":"B Mascher","year":"1999","unstructured":"Mascher B, Schlenke P, Seyfarth M (1999) Expression and kinetics of cytokines determined by intracellular staining using flow cytometry. J Immunol Methods 223(1):115\u2013121","journal-title":"J Immunol Methods"},{"issue":"5","key":"981_CR33","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1182\/blood-2001-11-0005","volume":"100","author":"M Eyrich","year":"2002","unstructured":"Eyrich M, Croner T, Leiler C, Lang P, Bader P, Klingebiel T, Niethammer D, Schlegel PG (2002) Distinct contributions of CD4(+) and CD8(+) naive and memory T-cell subsets to overall T-cell-receptor repertoire complexity following transplantation of T-cell-depleted CD34-selected hematopoietic progenitor cells from unrelated donors. Blood 100(5):1915\u20131918. doi: 10.1182\/blood-2001-11-0005","journal-title":"Blood"},{"issue":"3","key":"981_CR34","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbmt.2004.12.001","volume":"11","author":"M Eyrich","year":"2005","unstructured":"Eyrich M, Wollny G, Tzaribaschev N, Dietz K, Brugger D, Bader P, Lang P, Schilbach K, Winkler B, Niethammer D, Schlegel PG (2005) Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children. Biol Blood Marrow Transplant 11(3):194\u2013205. doi: 10.1016\/j.bbmt.2004.12.001","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"981_CR35","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/pbc.21064","volume":"48","author":"KW Sung","year":"2007","unstructured":"Sung KW, Yoo KH, Cho EJ, Koo HH, Lim do H, Shin HJ, Ahn SD, Ra YS, Choi ES, Ghim TT (2007) High-dose chemotherapy and autologous stem cell rescue in children with newly diagnosed high-risk or relapsed medulloblastoma or supratentorial primitive neuroectodermal tumor. Pediatr Blood Cancer 48(4):408\u2013415. doi: 10.1002\/pbc.21064","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"981_CR36","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ajh.10443","volume":"75","author":"H Guo","year":"2004","unstructured":"Guo H, Qiao Z, Zhu L, Wang H, Su L, Lu Y, Cui Y, Jiang B, Zhu Q, Xu L (2004) Th1\/Th2 cytokine profiles and their relationship to clinical features in patients following nonmyeloablative allogeneic stem cell transplantation. Am J Hematol 75(2):78\u201383. doi: 10.1002\/ajh.10443","journal-title":"Am J Hematol"},{"issue":"8","key":"981_CR37","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1097\/00007890-200204270-00025","volume":"73","author":"DK Mitra","year":"2002","unstructured":"Mitra DK, Singh HP, Singh M, Alwadi A, Kochupillai V, Raina V, Kumar L, Mehra NK (2002) Reconstitution of naive T cells and type 1 function after autologous peripheral stem cell transplantation: impact on the relapse of original cancer. Transplantation 73(8):1336\u20131339","journal-title":"Transplantation"},{"issue":"2","key":"981_CR38","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V96.2.754","volume":"96","author":"CL Mackall","year":"2000","unstructured":"Mackall CL, Stein D, Fleisher TA, Brown MR, Hakim FT, Bare CV, Leitman SF, Read EJ, Carter CS, Wexler LH, Gress RE (2000) Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults. Blood 96(2):754\u2013762","journal-title":"Blood"},{"issue":"5","key":"981_CR39","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1182\/blood.V92.5.1471","volume":"92","author":"T Guillaume","year":"1998","unstructured":"Guillaume T, Rubinstein DB, Symann M (1998) Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 92(5):1471\u20131490","journal-title":"Blood"},{"issue":"4","key":"981_CR40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.bmt.1703831","volume":"31","author":"S Hoepfner","year":"2003","unstructured":"Hoepfner S, Haut PR, O\u2019Gorman M, Kletzel M (2003) Rapid immune reconstitution following autologous hematopoietic stem cell transplantation in children: a single institution experience. Bone Marrow Transplant 31(4):285\u2013290. doi: 10.1038\/sj.bmt.1703831","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"981_CR41","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1365-2141.2002.03560.x","volume":"118","author":"K Kalwak","year":"2002","unstructured":"Kalwak K, Gorczynska E, Toporski J, Turkiewicz D, Slociak M, Ussowicz M, Latos-Grazynska E, Krol M, Boguslawska-Jaworska J, Chybicka A (2002) Immune reconstitution after haematopoietic cell transplantation in children: immunophenotype analysis with regard to factors affecting the speed of recovery. Br J Haematol 118(1):74\u201389","journal-title":"Br J Haematol"},{"issue":"5","key":"981_CR42","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00277-003-0630-4","volume":"82","author":"P Reimer","year":"2003","unstructured":"Reimer P, Kunzmann V, Wilhelm M, Weissbrich B, Kraemer D, Berghammer H, Weissinger F (2003) Cellular and humoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT). Ann Hematol 82(5):263\u2013270. doi: 10.1007\/s00277-003-0630-4","journal-title":"Ann Hematol"},{"issue":"1","key":"981_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CJI.0b013e3181837276","volume":"32","author":"V Bronte","year":"2009","unstructured":"Bronte V, Mocellin S (2009) Suppressive influences in the immune response to cancer. J Immunother 32(1):1\u201311. doi: 10.1097\/CJI.0b013e3181837276","journal-title":"J Immunother"},{"issue":"2","key":"981_CR44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1006\/cimm.1998.1244","volume":"183","author":"J Chipeta","year":"1998","unstructured":"Chipeta J, Komada Y, Zhang XL, Deguchi T, Sugiyama K, Azuma E, Sakurai M (1998) CD4\u00a0+\u00a0and CD8\u00a0+\u00a0cell cytokine profiles in neonates, older children, and adults: increasing T helper type 1 and T cytotoxic type 1 cell populations with age. Cell Immunol 183(2):149\u2013156. doi: 10.1006\/cimm.1998.1244","journal-title":"Cell Immunol"},{"issue":"4","key":"981_CR45","first-page":"283","volume":"16","author":"F Hoffmann","year":"2005","unstructured":"Hoffmann F, Albert MH, Arenz S, Bidlingmaier C, Berkowicz N, Sedlaczek S, Till H, Pawlita I, Renner ED, Weiss M, Belohradsky BH (2005) Intracellular T-cell cytokine levels are age-dependent in healthy children and adults. Eur Cytokine Netw 16(4):283\u2013288","journal-title":"Eur Cytokine Netw"},{"issue":"2","key":"981_CR46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1684\/ecn.2009.0149","volume":"20","author":"V Wiegering","year":"2009","unstructured":"Wiegering V, Eyrich M, Wunder C, Gunther H, Schlegel PG, Winkler B (2009) Age-related changes in intracellular cytokine expression in healthy children. Eur Cytokine Netw 20(2):75\u201380. doi: 10.1684\/ecn.2009.0149","journal-title":"Eur Cytokine Netw"},{"issue":"4","key":"981_CR47","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood.V90.4.1611","volume":"90","author":"PP Lee","year":"1997","unstructured":"Lee PP, Zeng D, McCaulay AE, Chen YF, Geiler C, Umetsu DT, Chao NJ (1997) T helper 2-dominant antilymphoma immune response is associated with fatal outcome. Blood 90(4):1611\u20131617","journal-title":"Blood"},{"issue":"10","key":"981_CR48","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00262-002-0309-z","volume":"51","author":"K Dredge","year":"2002","unstructured":"Dredge K, Marriott JB, Todryk SM, Dalgleish AG (2002) Adjuvants and the promotion of Th1-type cytokines in tumour immunotherapy. Cancer Immunol Immunother 51(10):521\u2013531. doi: 10.1007\/s00262-002-0309-z","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"981_CR49","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/jcp.10258","volume":"195","author":"MA Santana","year":"2003","unstructured":"Santana MA, Rosenstein Y (2003) What it takes to become an effector T cell: the process, the cells involved, and the mechanisms. J Cell Physiol 195(3):392\u2013401. doi: 10.1002\/jcp.10258","journal-title":"J Cell Physiol"},{"issue":"2","key":"981_CR50","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1023\/A:1022586726510","volume":"24","author":"B Popko","year":"1999","unstructured":"Popko B, Baerwald KD (1999) Oligodendroglial response to the immune cytokine interferon gamma. Neurochem Res 24(2):331\u2013338","journal-title":"Neurochem Res"},{"issue":"6","key":"981_CR51","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/00207450290025725","volume":"112","author":"D Sredni-Kenigsbuch","year":"2002","unstructured":"Sredni-Kenigsbuch D (2002) TH1\/TH2 cytokines in the central nervous system. Int J Neurosci 112(6):665\u2013703","journal-title":"Int J Neurosci"},{"issue":"5","key":"981_CR52","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1006\/mcne.1996.0026","volume":"7","author":"JG Corbin","year":"1996","unstructured":"Corbin JG, Kelly D, Rath EM, Baerwald KD, Suzuki K, Popko B (1996) Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 7(5):354\u2013370. doi: 10.1006\/mcne.1996.0026","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"981_CR53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/JMN:15:1:45","volume":"15","author":"FM LaFerla","year":"2000","unstructured":"LaFerla FM, Sugarman MC, Lane TE, Leissring MA (2000) Regional hypomyelination and dysplasia in transgenic mice with astrocyte-directed expression of interferon-gamma. J Mol Neurosci 15(1):45\u201359. doi: 10.1385\/JMN:15:1:45","journal-title":"J Mol Neurosci"},{"issue":"45","key":"981_CR54","doi-asserted-by":"crossref","first-page":"10074","DOI":"10.1523\/JNEUROSCI.2604-04.2004","volume":"24","author":"W Lin","year":"2004","unstructured":"Lin W, Kemper A, McCarthy KD, Pytel P, Wang JP, Campbell IL, Utset MF, Popko B (2004) Interferon-gamma induced medulloblastoma in the developing cerebellum. J Neurosci 24(45):10074\u201310083. doi: 10.1523\/JNEUROSCI.2604-04.2004","journal-title":"J Neurosci"},{"issue":"17","key":"981_CR55","first-page":"6401","volume":"9","author":"C Pingoud-Meier","year":"2003","unstructured":"Pingoud-Meier C, Lang D, Janss AJ, Rorke LB, Phillips PC, Shalaby T, Grotzer MA (2003) Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. Clin Cancer Res 9(17):6401\u20136409","journal-title":"Clin Cancer Res"},{"issue":"1","key":"981_CR56","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.leu.2403553","volume":"19","author":"T Cloppenborg","year":"2005","unstructured":"Cloppenborg T, Stanulla M, Zimmermann M, Schrappe M, Welte K, Klein C (2005) Immunosurveillance of childhood ALL: polymorphic interferon-gamma alleles are associated with age at diagnosis and clinical risk groups. Leukemia 19(1):44\u201348. doi: 10.1038\/sj.leu.2403553","journal-title":"Leukemia"},{"issue":"7","key":"981_CR57","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/pbc.21971","volume":"52","author":"L Dai","year":"2009","unstructured":"Dai L, Gast A, Horska A, Schrappe M, Bartram CR, Hemminki K, Kumar R, Bermejo JL (2009) A case-control study of childhood acute lymphoblastic leukaemia and polymorphisms in the TGF-beta and receptor genes. Pediatr Blood Cancer 52(7):819\u2013823. doi: 10.1002\/pbc.21971","journal-title":"Pediatr Blood Cancer"},{"issue":"33","key":"981_CR58","doi-asserted-by":"crossref","first-page":"8414","DOI":"10.1200\/JCO.2005.01.2179","volume":"23","author":"K Seidemann","year":"2005","unstructured":"Seidemann K, Zimmermann M, Book M, Meyer U, Burkhardt B, Welte K, Reiter A, Stanulla M (2005) Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin\u2019s lymphoma: results from Berlin-Frankfurt-Munster Trial NHL-BFM 95. J Clin Oncol 23(33):8414\u20138421. doi: 10.1200\/JCO.2005.01.2179","journal-title":"J Clin Oncol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-011-0981-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-011-0981-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-011-0981-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T14:50:58Z","timestamp":1592319058000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-011-0981-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,16]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["981"],"URL":"https:\/\/doi.org\/10.1007\/s00262-011-0981-y","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,16]]}}}